Skip to main content

Advertisement

SpringerLink
Log in

Controversies and challenges in the management of well-differentiated thyroid cancer

  • Review Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

The incidence of well-differentiated thyroid cancer has seen a worldwide increase in the last three decades, although whether this is due to a ‘true increase’ in incidence or simply increased detection of otherwise subclinical disease remains undetermined. Nonetheless, this rising incidence has fuelled an interest in early diagnosis, treatment and follow-up of thyroid cancer along with greater public awareness. The treatment of thyroid cancer revolves around appropriate surgical intervention, minimising complications and the use of adjuvant therapy in select circumstances. Prognostic features and risk stratification are crucial in determining the appropriate treatment. There continues to be considerable debate in several aspects of management in these patients, and there is limited prospective data to direct therapy, hence limiting decision-making to retrospective analyses, treatment guidelines based on expert opinion and personal philosophies. The major controversies are related to diagnostic work-up, extent of surgery and postoperative management including the role of radioactive iodine. There are also differences in opinion regarding management of nodal metastases and follow-up protocols. As overall survival in well-differentiated thyroid cancer exceeds 95%, it is important to reduce over-treating the large majority of patients, and focus limited resources on high-risk patients who require aggressive treatment and closer attention. There needs to be a concerted effort on the part of a multidisciplinary team to recognise the nuances in treating well-differentiated thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. dos Santos Silva I, Swerdlow AJ (1993) Thyroid cancer epidemiology in England and Wales: Time trends and geographical distribution. Br J Cancer 67(2):330–340

    PubMed  Google Scholar 

  2. Pettersson B, Adami HO, Wilander E, Coleman MP (1991) Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 48(1):28–33

    CAS  PubMed  Google Scholar 

  3. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167

    Article  CAS  PubMed  Google Scholar 

  4. Randolph GW, Thompson GB, Branovan DI, Tuttle RM (2007) Treatment of thyroid cancer: A basic review. Int J Radiat Oncol Biol Phys 69(2 Suppl):S92–97

    PubMed  Google Scholar 

  5. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see commetns]. Cancer 83(12):2638–2648

    Article  CAS  PubMed  Google Scholar 

  6. Bilimoria KY, Bentrem DJ, Ko CY, et al. (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246(3):375–381; discussion 381–384

    Article  PubMed  Google Scholar 

  7. Atli M, Akgul M, Saryal M, Daglar G, Yasti AC, Kama NA (2006) Thyroid incidentalomas: Prediction of malignancy and management. Int Surg 91(4):237–244

    PubMed  Google Scholar 

  8. Gough J, Scott-Coombes D, Fausto Palazzo F (2008) Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg 32(7):1264–1268

    Article  PubMed  Google Scholar 

  9. Howlett DC, Speirs A (2007) The thyroid incidentaloma-ignore or investigate? J Ultrasound Med 26(10):1367–1371

    PubMed  Google Scholar 

  10. Frates MC, Benson CB, Charboneau JW, et al. (2006) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 22(4):231–238; discussion 239–240

    Article  PubMed  Google Scholar 

  11. Kim EK, Park CS, Chung WY, et al. (2002) New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 178(3):687–691

    PubMed  Google Scholar 

  12. Katz SC, Shaha A (2008) PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 207(2):259–264

    Article  PubMed  Google Scholar 

  13. Robbins RJ, Wan Q, Grewal RK, et al. (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91(2):498–505

    Article  CAS  PubMed  Google Scholar 

  14. Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR (2007) Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol 14(11):3210–3215

    Article  PubMed  Google Scholar 

  15. Papini E, Guglielmi R, Bianchini A, et al. (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87(5):1941–1946

    Article  CAS  PubMed  Google Scholar 

  16. Shaha AR (2000) Controversies in the management of thyroid nodule. Laryngoscope 110(2 Pt 1):183–193

    Article  CAS  PubMed  Google Scholar 

  17. Shaha AR (2005) Advances in the management of thyroid cancer. Int J Surg 3(3):213–220

    Article  PubMed  Google Scholar 

  18. Leenhardt L, Hejblum G, Franc B, et al. (1999) Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 84(1):24–28

    Article  CAS  PubMed  Google Scholar 

  19. Shah JP, Loree TR, Dharker D, Strong EW (1993) Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 166(4):331–335

    Article  CAS  PubMed  Google Scholar 

  20. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V (1992) Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164(6):658–661

    Article  CAS  PubMed  Google Scholar 

  21. Shaha A (2008) Selective surgical management of well-differentiated thyroid cancer. Ann N Y Acad Sci 1138:58–64

    Article  PubMed  Google Scholar 

  22. Grillo HC, Suen HC, Mathisen DJ, Wain JC (1992) Resectional management of thyroid carcinoma invading the airway. Ann Thorac Surg 54(1):3–9; discussion 9–10

    Article  CAS  PubMed  Google Scholar 

  23. Clayman GL, Shellenberger TD, Ginsberg LE, et al. (2009) Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31(9):1152–1163

    Article  PubMed  Google Scholar 

  24. Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19(7):683–689

    Article  PubMed  Google Scholar 

  25. Sugitani I, Fujimoto Y, Yamada K, Yamamoto N (2008) Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg 32(11):2494–2502.

    Article  PubMed  Google Scholar 

  26. Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119(6):1135–1139

    Article  PubMed  Google Scholar 

  27. Grubbs EG, Evans DB (2007) Role of lymph node dissection in primary surgery for thyroid cancer. J Natl Compr Canc Netw 5(6):623–630

    PubMed  Google Scholar 

  28. Patel KN, Shaha AR (2005) Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg 13(2):112–116

    Article  PubMed  Google Scholar 

  29. Tuttle RM, Grewal RK, Larson SM (2007) Radioactive iodine therapy in poorly differentiated thyroid cancer. Nat Clin Pract Oncol 4(11):665–668

    Article  CAS  PubMed  Google Scholar 

  30. Tuttle RM, Leboeuf R, Shaha AR (2008) Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol 97(8):712–716

    Article  PubMed  Google Scholar 

  31. Hay ID, Thompson GB, Grant CS, et al. (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26(8):879–885

    Article  PubMed  Google Scholar 

  32. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428

    Article  CAS  PubMed  Google Scholar 

  33. Mazzaferri EL, Jhiang SM (1995) Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc 106:151–168 discussion 168–170

    CAS  PubMed  Google Scholar 

  34. Tuttle RM, Leboeuf R (2007) Investigational therapies for metastatic thyroid carcinoma. J Natl Compr Canc Netw 5(6):641–646

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, USA

    N. Gopalakrishna Iyer & Ashok R. Shaha

Authors
  1. N. Gopalakrishna Iyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashok R. Shaha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok R. Shaha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iyer, N.G., Shaha, A.R. Controversies and challenges in the management of well-differentiated thyroid cancer. Indian J Surg 71, 299–307 (2009). https://doi.org/10.1007/s12262-009-0084-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-009-0084-6

Keywords

Search

Navigation